person · Reporting owner
THOMAS H LEE PARTNERS LP
Disclosed activity across 6 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Syneos Health, Inc.SYNH · Entity 109360 | Director | June 07, 2021 | June 09, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Syneos Health, Inc.
Report date June 07, 2021 · Filed June 09, 2021
Jointly reported with THOMAS H. LEE ADVISORS, LLC, Thomas H. Lee Equity Fund VI (2019), L.P., THL Fund VI (2019) Coinvestment Partners, L.P., Thomas H. Lee Equity Fund VII, L.P., Thomas H. Lee Parallel Fund VII, L.P., Thomas H. Lee Parallel (Cayman) Fund VII, L.P., THL Managers VI, LLC, THL Managers VII, LLC, THL HOLDCO, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 391,991 |
Reported balance
After 2021-06-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-06-07 · Sale · Disposed 4,816,880 · Balance 391,991 F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3). |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2021-06-07 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-06-07 · Sale · Disposed 226,128 · Balance 0 F6: See Exhibit 99.1 for text of footnote (6). F7: See Exhibit 99.1 for text of footnote (7). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3). |
| Class A Common StockSEC Table I · non-derivative | Direct | 37 |
Reported balance
After 2021-06-07 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2021-06-07 · Sale · Disposed 815 · Balance 37 F8: See Exhibit 99.1 for text of footnote (8). F10: See Exhibit 99.1 for text of footnote (10). |
| Class A Common StockSEC Table I · non-derivative | Direct | 14 |
Reported balance
After 2021-06-07 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2021-06-07 · Sale · Disposed 313 · Balance 14 F9: See Exhibit 99.1 for text of footnote (9). F11: See Exhibit 99.1 for text of footnote (11). |
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-07 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2021-06-07 · Sale · Disposed 37 · Balance 0 F12: See Exhibit 99.1 for text of footnote (12). F14: See Exhibit 99.1 for text of footnote (14). |
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-07 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2021-06-07 · Sale · Disposed 14 · Balance 0 F13: See Exhibit 99.1 for text of footnote (13). F15: See Exhibit 99.1 for text of footnote (15). |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of footnote (1).
F2: See Exhibit 99.1 for text of footnote (2).
F3: See Exhibit 99.1 for text of footnote (3).
F4: See Exhibit 99.1 for text of footnote (4).
F5: See Exhibit 99.1 for text of footnote (5).
F6: See Exhibit 99.1 for text of footnote (6).
F7: See Exhibit 99.1 for text of footnote (7).
F8: See Exhibit 99.1 for text of footnote (8).
F9: See Exhibit 99.1 for text of footnote (9).
F10: See Exhibit 99.1 for text of footnote (10).
F11: See Exhibit 99.1 for text of footnote (11).
F12: See Exhibit 99.1 for text of footnote (12).
F13: See Exhibit 99.1 for text of footnote (13).
F14: See Exhibit 99.1 for text of footnote (14).
F15: See Exhibit 99.1 for text of footnote (15).
Past disclosures · reporting ended (5)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AGILITI, INC. \DE
Report date May 07, 2024 · Filed May 07, 2024
Jointly reported with THL AGILITI LLC, THOMAS H. LEE ADVISORS, LLC, Thomas H. Lee Equity Fund VIII, L.P., Thomas H. Lee Parallel Fund VIII, L.P., THL Executive Fund VIII, L.P., THL FUND VIII COINVESTMENT PARTNERS, L.P., THL EQUITY ADVISORS VIII, LLC, THL HOLDCO, LLC, THL MANAGERS VIII, LLC
Section 16 reporting ended · disclosed 2024-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2024-05-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-05-07 · Disposition to issuer · Disposed 98,195,398 · Balance 0 F1: See Exhibit 99.1 for text of Footnote 1. F2: See Exhibit 99.1 for text of Footnote 2. F3: See Exhibit 99.1 for text of Footnote 3. F4: See Exhibit 99.1 for text of Footnote 4. |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of Footnote 1.
F2: See Exhibit 99.1 for text of Footnote 2.
F3: See Exhibit 99.1 for text of Footnote 3.
F4: See Exhibit 99.1 for text of Footnote 4.
Dayforce, Inc.
Report date August 28, 2020 · Filed August 31, 2020
Jointly reported with THOMAS H. LEE ADVISORS, LLC, THL HOLDCO, LLC, Thomas H. Lee Equity Fund VI, L.P., Thomas H. Lee Parallel Fund VI, L.P., Thomas H. Lee Parallel (DT) Fund VI, L.P., THL Equity Fund VI Investors (Ceridian), L.P., THL Equity Fund VI Investors (Ceridian) II, L.P., THL Equity Fund VI Investors (Ceridian) III, LLC, THL Equity Fund VI Investors (Ceridian) IV, LLC
Section 16 reporting ended · disclosed 2020-02-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2020-08-28 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-08-28 · Sale · Disposed 7,217,347 · Balance 0 F4: See Exhibit 99.1 for text of footnote (4) F5: See Exhibit 99.1 for text of footnote (5) F1: See Exhibit 99.1 for text of footnote (1) F2: See Exhibit 99.1 for text of footnote (2) F3: See Exhibit 99.1 for text of footnote (3) |
| Common StockSEC Table I · non-derivative | Direct | 38,824 |
Reported balance
Holding disclosure · report date 2020-08-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 38,824 F6: See Exhibit 99.1 for text of footnote (6) F9: See Exhibit 99.1 for text of footnote (9) |
| Common StockSEC Table I · non-derivative | Direct | 129,656 |
Reported balance
Holding disclosure · report date 2020-08-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 129,656 F7: See Exhibit 99.1 for text of footnote (7) F9: See Exhibit 99.1 for text of footnote (9) |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 114,235 |
Reported balance
Holding disclosure · report date 2020-08-28 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 114,235 F8: See Exhibit 99.1 for text of footnote (8) |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of footnote (1)
F2: See Exhibit 99.1 for text of footnote (2)
F3: See Exhibit 99.1 for text of footnote (3)
F4: See Exhibit 99.1 for text of footnote (4)
F5: See Exhibit 99.1 for text of footnote (5)
F6: See Exhibit 99.1 for text of footnote (6)
F7: See Exhibit 99.1 for text of footnote (7)
F8: See Exhibit 99.1 for text of footnote (8)
F9: See Exhibit 99.1 for text of footnote (9)
Dun & Bradstreet Holdings, Inc.
Report date August 26, 2025 · Filed August 26, 2025
Jointly reported with THOMAS H. LEE ADVISORS, LLC, Thomas H. Lee Equity Fund VIII, L.P., Thomas H. Lee Parallel Fund VIII, L.P., THL FUND VIII COINVESTMENT PARTNERS, L.P., THL Executive Fund VIII, L.P., THL Equity Fund VIII Investors (D&B), L.P., THL EQUITY ADVISORS VIII, LLC, THL MANAGERS VIII, LLC, THL HOLDCO, LLC
Section 16 reporting ended · disclosed 2025-08-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2025-08-26 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-08-26 · Disposition to issuer · Disposed 22,525,103 · Balance 0 F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F5: See Exhibit 99.1 for text of footnote (5). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-08-26 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2025-08-26 · Disposition to issuer · Disposed 42,949 · Balance 0 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F4: See Exhibit 99.1 for text of footnote (4). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-08-26 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2025-08-26 · Disposition to issuer · Disposed 42,949 · Balance 0 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F4: See Exhibit 99.1 for text of footnote (4). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-08-26 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2025-08-26 · Disposition to issuer · Disposed 58,210 · Balance 0 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F4: See Exhibit 99.1 for text of footnote (4). |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of footnote (1).
F2: See Exhibit 99.1 for text of footnote (2).
F3: See Exhibit 99.1 for text of footnote (3).
F4: See Exhibit 99.1 for text of footnote (4).
F5: See Exhibit 99.1 for text of footnote (5).
Federal Street Acquisition Corp.
Report date January 04, 2019 · Filed January 04, 2019
Jointly reported with THL AGILITI LLC, THOMAS H. LEE ADVISORS, LLC, Thomas H. Lee Equity Fund VIII, L.P., Thomas H. Lee Parallel Fund VIII, L.P., THL Executive Fund VIII, L.P., THL FUND VIII COINVESTMENT PARTNERS, L.P., THL EQUITY ADVISORS VIII, LLC, THL HOLDCO, LLC, THL MANAGERS VIII, LLC
Section 16 reporting ended · disclosed 2019-01-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Last balance in matching sequence
After 2019-01-04 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2019-01-04 · Conversion · Acquired 11,400,000 · Balance 98,195,398 F1: See Exhibit 99.1 for text of footnotes. F3: See Exhibit 99.1 for text of footnotes. F4: See Exhibit 99.1 for text of footnotes. F5: See Exhibit 99.1 for text of footnotes. Row 2 · 2019-01-04 · Disposition to issuer · Disposed 98,195,398 · Balance 0 F2: See Exhibit 99.1 for text of footnotes. F3: See Exhibit 99.1 for text of footnotes. F4: See Exhibit 99.1 for text of footnotes. F5: See Exhibit 99.1 for text of footnotes. |
| Class F Common Stock, par value $0.0001 per shareSEC Table II · derivative / convertible security | IndirectSee footnotes | 0 |
Reported balance
After 2019-01-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-01-04 · Conversion · Disposed 11,400,000 · Balance 0 F1: See Exhibit 99.1 for text of footnotes. F3: See Exhibit 99.1 for text of footnotes. F4: See Exhibit 99.1 for text of footnotes. F5: See Exhibit 99.1 for text of footnotes. |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of footnotes.
F2: See Exhibit 99.1 for text of footnotes.
F3: See Exhibit 99.1 for text of footnotes.
F4: See Exhibit 99.1 for text of footnotes.
F5: See Exhibit 99.1 for text of footnotes.
iHeartMedia, Inc.
Report date May 01, 2019 · Filed May 03, 2019
Jointly reported with THOMAS H. LEE ADVISORS, LLC, THL Equity Advisors VI, LLC, Thomas H. Lee Equity Fund VI, L.P., Thomas H. Lee Parallel Fund VI, L.P., Thomas H. Lee Parallel (DT) Fund VI, L.P., THL Coinvestment Partners, L.P., THL Operating Partners, L.P., THL HOLDCO, LLC, THL Equity Fund VI Investors (Clear Channel), L.P.
Section 16 reporting ended · disclosed 2019-05-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 294,458.5 |
Reported balance
After 2019-05-01 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2019-05-01 · Grant · Acquired 294,458.5 · Balance 294,458.5 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F4: See Exhibit 99.1 for text of footnote (4). F7: See Exhibit 99.1 for text of footnote (7). F8: See Exhibit 99.1 for text of footnote (8). |
| Class B Common Stock, $0.001 par value per shareSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2019-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-01 · Disposition to issuer · Disposed 277,778 · Balance 0 F9: See Exhibit 99.1 for text of footnote (9). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F5: See Exhibit 99.1 for text of footnote (5). F7: See Exhibit 99.1 for text of footnote (7). |
| Class C Common Stock, $0.001 par value per shareSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2019-05-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-05-01 · Disposition to issuer · Disposed 29,483,751 · Balance 0 F9: See Exhibit 99.1 for text of footnote (9). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F6: See Exhibit 99.1 for text of footnote (6). F8: See Exhibit 99.1 for text of footnote (8). |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectSee footnotes | 102,642 |
Reported balance
After 2019-05-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-05-01 · Grant · Acquired 103,142 · Balance 102,642 F1: See Exhibit 99.1 for text of footnote (1). F3: See Exhibit 99.1 for text of footnote (3). F10: See Exhibit 99.1 for text of footnote (10). F11: See Exhibit 99.1 for text of footnote (11). F7: See Exhibit 99.1 for text of footnote (7). F8: See Exhibit 99.1 for text of footnote (8). |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of footnote (1).
F2: See Exhibit 99.1 for text of footnote (2).
F3: See Exhibit 99.1 for text of footnote (3).
F4: See Exhibit 99.1 for text of footnote (4).
F5: See Exhibit 99.1 for text of footnote (5).
F6: See Exhibit 99.1 for text of footnote (6).
F7: See Exhibit 99.1 for text of footnote (7).
F8: See Exhibit 99.1 for text of footnote (8).
F9: See Exhibit 99.1 for text of footnote (9).
F10: See Exhibit 99.1 for text of footnote (10).
F11: See Exhibit 99.1 for text of footnote (11).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2025 Filed Aug 26, 2025 16:55 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | Disposition to issuerCommon Stock | 58,210 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-25-032748 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: See Exhibit 99.1 for text of footnote (1). F3 · kind: See Exhibit 99.1 for text of footnote (3). F3 · shares: See Exhibit 99.1 for text of footnote (3). F4 · shares: See Exhibit 99.1 for text of footnote (4). F3 · price: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| August 26, 2025 Filed Aug 26, 2025 16:55 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | Disposition to issuerCommon Stock | 42,949 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-25-032748 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: See Exhibit 99.1 for text of footnote (1). F3 · kind: See Exhibit 99.1 for text of footnote (3). F3 · shares: See Exhibit 99.1 for text of footnote (3). F4 · shares: See Exhibit 99.1 for text of footnote (4). F3 · price: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| August 26, 2025 Filed Aug 26, 2025 16:55 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | Disposition to issuerCommon Stock | 42,949 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-25-032748 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: See Exhibit 99.1 for text of footnote (1). F3 · shares: See Exhibit 99.1 for text of footnote (3). F4 · shares: See Exhibit 99.1 for text of footnote (4). F3 · price: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| August 26, 2025 Filed Aug 26, 2025 16:55 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | Disposition to issuerCommon Stock | 22,525,103 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-25-032748 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: See Exhibit 99.1 for text of footnote (1). F2 · shares: See Exhibit 99.1 for text of footnote (2). F2 · price: See Exhibit 99.1 for text of footnote (2). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:26 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantCommon Stock | 23,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-008509 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,949 F4 · shares: See Exhibit 99.1 for text of footnote (4). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:26 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantCommon Stock | 23,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-008509 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,949 F4 · shares: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| May 07, 2024 Filed May 7, 2024 10:27 UTC | AGILITI, INC. \DE AGTI · Entity 91354 | Disposition to issuerCommon Stock, par value $0.0001 per share | 98,195,398 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054044 · ownership.xml · nonDerivative · entry 1 THL AGILITI LLC · CIK 0001756402 · Director · 10% owner THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · kind: See Exhibit 99.1 for text of Footnote 1. F1 · price: See Exhibit 99.1 for text of Footnote 1. F1 · ownership.nature: See Exhibit 99.1 for text of Footnote 1. F2 · ownership.nature: See Exhibit 99.1 for text of Footnote 2. F3 · ownership.nature: See Exhibit 99.1 for text of Footnote 3. F4 · ownership.nature: See Exhibit 99.1 for text of Footnote 4. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 19:24 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantClass A Common Stock | 19,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-013086 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director THL Executive Fund VIII, L.P. · CIK 0001718514 · Director THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL MANAGERS VIII, LLC · CIK 0001757240 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,192 F4 · shares: See Exhibit 99.1 for text of footnote (4). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 19:24 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantClass A Common Stock | 19,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-013086 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director THL Executive Fund VIII, L.P. · CIK 0001718514 · Director THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL MANAGERS VIII, LLC · CIK 0001757240 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,192 F4 · shares: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 16:43 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | SaleClass A Common Stock | 13,396,742 | $9.51 | $127,429,809.90 |
DisclosureSEC source: 0001140361-23-052482 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director THL Executive Fund VIII, L.P. · CIK 0001718514 · Director THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL MANAGERS VIII, LLC · CIK 0001757240 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 22,525,103 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F9 · ownership.nature: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 16:47 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | SaleClass A Common Stock | 13,657,926 | $11.12 | $151,807,847.49 |
DisclosureSEC source: 0001140361-23-038829 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 35,921,845 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 17:56 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantClass A Common Stock | 11,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-011659 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,105 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 17:56 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantClass A Common Stock | 11,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-011659 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,105 F5 · shares: See Exhibit 99.1 for text of footnote (5). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 19:19 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | SaleClass A Common Stock | 8,287,846 | $13.41 | $111,098,575.63 |
DisclosureSEC source: 0001140361-22-042632 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 49,579,771 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:56 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantClass A Common Stock | 7,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-009474 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,052 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:56 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantClass A Common Stock | 7,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-009474 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,052 F5 · shares: See Exhibit 99.1 for text of footnote (5 F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:43 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | OtherClass A Common Stock | 9,515,754 | $19.88 | $189,218,865.14 |
DisclosureSEC source: 0000899243-22-006835 · doc4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 57,867,617 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F1 · price: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F6 · ownership.nature: See Exhibit 99.1 for text of footnote (6). Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 17:30 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | OtherClass A Common Stock | 55,467,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-134517 · tm2131819-1_4seq1.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner THL FUND VIII COINVESTMENT PARTNERS, L.P. · CIK 0001756407 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 48,351,863 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F1 · price: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 14 | $81.20 | $1,136.80 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F13 · shares: See Exhibit 99.1 for text of footnote (13). F15 · balance_after: See Exhibit 99.1 for text of footnote (15). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 37 | $81.20 | $3,004.40 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F12 · shares: See Exhibit 99.1 for text of footnote (12). F14 · balance_after: See Exhibit 99.1 for text of footnote (14). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 313 | $81.20 | $25,415.60 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 815 | $81.20 | $66,178.00 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 226,128 | $81.20 | $18,361,593.60 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 4,816,880 | $81.20 | $391,130,656.00 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 391,991 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:55 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 2,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017529 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,392 F7 · shares: See Exhibit 99.1 for text of footnote (7). F7 · price: See Exhibit 99.1 for text of footnote (7). F9 · price: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:55 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 2,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017529 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,392 F7 · shares: See Exhibit 99.1 for text of footnote (7). F7 · price: See Exhibit 99.1 for text of footnote (7). F8 · price: See Exhibit 99.1 for text of footnote (8). Read SEC document |
| May 12, 2021 Filed May 18, 2021 21:49 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 25 | $81.04 | $2,026.00 |
DisclosureSEC source: 0001140361-21-017952 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 F8 · shares: See Exhibit 99.1 for text of footnote (8). F4 · price: See Exhibit 99.1 for text of footnote (4). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| May 12, 2021 Filed May 18, 2021 21:49 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 64 | $81.04 | $5,186.56 |
DisclosureSEC source: 0001140361-21-017952 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852 F7 · shares: See Exhibit 99.1 for text of footnote (7). F4 · price: See Exhibit 99.1 for text of footnote (4). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| May 12, 2021 Filed May 18, 2021 21:49 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 379,789 | $81.04 | $30,778,100.56 |
DisclosureSEC source: 0001140361-21-017952 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,208,835 F5 · shares: See Exhibit 99.1 for text of footnote (5). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| May 12, 2021 Filed May 20, 2021 21:45 UTC Amendment | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 25 | $81.04 | $2,026.00 |
DisclosureSEC source: 0001140361-21-018265 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 F8 · shares: See Exhibit 99.1 for text of footnote (8). F4 · price: See Exhibit 99.1 for text of footnote (4). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| May 12, 2021 Filed May 20, 2021 21:45 UTC Amendment | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 64 | $81.04 | $5,186.56 |
DisclosureSEC source: 0001140361-21-018265 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852 F7 · shares: See Exhibit 99.1 for text of footnote (7). F4 · price: See Exhibit 99.1 for text of footnote (4). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| May 12, 2021 Filed May 20, 2021 21:45 UTC Amendment | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 379,789 | $81.04 | $30,778,100.56 |
DisclosureSEC source: 0001140361-21-018265 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,208,871 F5 · shares: See Exhibit 99.1 for text of footnote (5). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 12 | $81.04 | $972.48 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352 F13 · shares: See Exhibit 99.1 for text of footnote F15 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 30 | $81.04 | $2,431.20 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 916 F12 · shares: See Exhibit 99.1 for text of footnote F14 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 208 | $81.04 | $16,856.32 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364 F9 · shares: See Exhibit 99.1 for text of footnote F11 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 544 | $81.04 | $44,085.76 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946 F8 · shares: See Exhibit 99.1 for text of footnote F10 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 183,292 | $81.04 | $14,853,983.68 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,601,430 F6 · shares: See Exhibit 99.1 for text of footnote F7 · balance_after: See Exhibit 99.1 for text of footnote F1 · ownership.nature: See Exhibit 99.1 for text of footnote F2 · ownership.nature: See Exhibit 99.1 for text of footnote F3 · ownership.nature: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,207,596 | $81.04 | $259,943,579.84 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,899,055 F4 · shares: See Exhibit 99.1 for text of footnote F5 · balance_after: See Exhibit 99.1 for text of footnote F1 · ownership.nature: See Exhibit 99.1 for text of footnote F2 · ownership.nature: See Exhibit 99.1 for text of footnote F3 · ownership.nature: See Exhibit 99.1 for text of footnote Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 21:56 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantClass A Common Stock | 5,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-008405 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,512 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 21:56 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantClass A Common Stock | 5,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-008405 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VIII, L.P. · CIK 0001718537 · Director · 10% owner Thomas H. Lee Parallel Fund VIII, L.P. · CIK 0001718511 · Director · 10% owner THL Executive Fund VIII, L.P. · CIK 0001718514 · Director · 10% owner THL Equity Fund VIII Investors (D&B), L.P. · CIK 0001816685 · Director · 10% owner THL EQUITY ADVISORS VIII, LLC · CIK 0001757180 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL MANAGERS VIII, LLC · CIK 0001757240 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,512 F5 · shares: See Exhibit 99.1 for text of footnote (5). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 17 | $74.18 | $1,260.98 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572 F13 · shares: See Exhibit 99.1 for text of footnote (13). F15 · balance_after: See Exhibit 99.1 for text of footnote (15). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 45 | $74.18 | $3,337.88 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490 F12 · shares: See Exhibit 99.1 for text of footnote (12). F14 · balance_after: See Exhibit 99.1 for text of footnote (14). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 242 | $74.18 | $17,950.35 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 631 | $74.18 | $46,804.43 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 277,114 | $74.18 | $20,554,930.95 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,106,651 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,717,905 | $74.18 | $275,775,603.38 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,517,640 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 17:05 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 174 | $61.28 | $10,662.72 |
DisclosureSEC source: 0001140361-20-027518 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 17:05 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 453 | $61.28 | $27,759.84 |
DisclosureSEC source: 0001140361-20-027518 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,166 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 17:05 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 2,771,132 | $61.28 | $169,814,968.96 |
DisclosureSEC source: 0001140361-20-027518 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,235,545 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 17:30 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 203 | $59.26 | $12,029.78 |
DisclosureSEC source: 0001140361-20-021021 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.